Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies
Wang, Yuqi, Quan, Quan, Gleason, Camille, Yu, Helin, Peng, Lujia, Kang, Yanshen, Jiang, Ling, Wu, Kailun, Pan, Jie, Bao, Moxiyele, Zhu, Qing, Yi, Meiqi, Fang, Ming, Zheng, Yue, Qiu, Ling, Xu, Bin, Li, Xiang, Song, Jinfeng, Sun, Jiamu, Zhang, Zheng, Su, Zijun, Lin, Jara, Xie, Yuanyuan, Xu, April, Song, Xiling, Huang, Chichi, Shen, Zhirong, Wang, Lai, Song, Jing
Published in mAbs (2023)
Published in mAbs (2023)
Get full text
Journal Article
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies
Wang, Yuqi, Quan, Quan, Gleason, Camille, Yu, Helin, Peng, Lujia, Kang, Yanshen, Jiang, Ling, Wu, Kailun, Pan, Jie, Bao, Moxiyele, Zhu, Qing, Yi, Meiqi, Fang, Ming, Zheng, Yue, Qiu, Ling, Xu, Bin, Li, Xiang, Song, Jinfeng, Sun, Jiamu, Zhang, Zheng, Su, Zijun, Lin, Jara, Xie, Yuanyuan, Xu, April, Song, Xiling, Huang, Chichi, Shen, Zhirong, Wang, Lai, Song, Jing
Published in mAbs (31.12.2023)
Published in mAbs (31.12.2023)
Get full text
Report